Elevated levels of IP-10 have been observed in various cancers and are associated with tumor progression, angiogenesis, and immune cell infiltration (Karin and Razon, 2018; Chen et al., 2020; Wu et al., 2021; Limagne et al., 2022). Here, CXCL10 is linked to cancer.